We are live on ! Find out more
WCA

Westover Capital Advisors Portfolio holdings

AUM $602M
1-Year Est. Return 37.09%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+37.09%
3 Year Est. Return
+133.23%
5 Year Est. Return
+171.88%
10 Year Est. Return
+595.98%
AUM
$454M
AUM Growth
-$65.9M
Cap. Flow
-$80.4M
Cap. Flow %
-17.7%
Top 10 Hldgs %
35.01%
Holding
255
New
12
Increased
32
Reduced
120
Closed
18

Top Buys

Rank Stock Value
1
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.79M
2
USFD icon
US Foods
USFD
+$1.12M
3
PR
Permian Resources
PR
+$983K
4
CTVA icon
Corteva
CTVA
+$966K
5
NVDA icon
NVIDIA
NVDA
+$892K

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Miscellaneous 20.46%
3 Financials 9.99%
4 Communication Services 8.06%
5 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
201
DELISTED
Catalyst Pharmaceutical
CPRX
$261K 0.06%
12,505
-270
-2% -$5.8K
BNS icon
202
Scotiabank
BNS
$114B
$261K 0.06%
4,850
COP icon
203
ConocoPhillips
COP
$170B
$260K 0.06%
2,623
-1,813
-41% -$192K
KMI icon
204
Kinder Morgan
KMI
$68.5B
$260K 0.06%
9,472
INFY icon
205
Infosys
INFY
$45.8B
$259K 0.06%
11,800
SPOT icon
206
Spotify
SPOT
$115B
$246K 0.05%
550
SYK icon
207
Stryker
SYK
$108B
$239K 0.05%
665
-450
-40% -$167K
PFE icon
208
Pfizer
PFE
$157B
$238K 0.05%
8,989
-3,375
-27% -$91.5K
BABA icon
209
Alibaba
BABA
$272B
$237K 0.05%
2,800
VCEL icon
210
Vericel Corp
VCEL
$2.03B
$237K 0.05%
4,322
-2,281
-35% -$115K
XLB icon
211
State Street Materials Select Sector SPDR ETF
XLB
$8.39B
$237K 0.05%
5,630
BMY icon
212
Bristol-Myers Squibb
BMY
$130B
$237K 0.05%
4,182
NTRS icon
213
Northern Trust
NTRS
$32.7B
$233K 0.05%
2,275
DHR icon
214
Danaher
DHR
$147B
$230K 0.05%
1,000
-600
-38% -$147K
GE icon
215
GE Aerospace
GE
$319B
$230K 0.05%
1,376
+66
+5% +$11.8K
REGN icon
216
Regeneron Pharmaceuticals
REGN
$79.7B
$228K 0.05%
320
VOO icon
217
Vanguard S&P 500 ETF
VOO
$1.04T
$227K 0.05%
422
-312
-43% -$169K
JEPI icon
218
JPMorgan Equity Premium Income ETF
JEPI
$45.2B
$224K 0.05%
3,897
-4,035
-51% -$240K
CBT icon
219
Cabot Corp
CBT
$4.09B
$222K 0.05%
2,435
-5,033
-67% -$541K
ARM icon
220
Arm
ARM
$258B
$222K 0.05%
1,800
UBS icon
221
UBS Group
UBS
$158B
$221K 0.05%
7,300
WDFC icon
222
WD-40
WDFC
$2.55B
$218K 0.05%
900
SBUX icon
223
Starbucks
SBUX
$110B
$216K 0.05%
2,363
-37
-2% -$3.58K
DUK icon
224
Duke Energy
DUK
$91.8B
$215K 0.05%
2,000
-100
-5% -$11.3K
TGTX icon
225
TG Therapeutics
TGTX
$8.12B
$214K 0.05%
+7,107
New +$204K

Similar funds

Westover Capital Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Westover Capital Advisors held 255 positions worth $454M, down 13% from $520M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Westover Capital Advisors withdrew a net $80.4M in Q4 2024, closing 18 positions and reducing 120 holdings. Its most notable exit was AstraZeneca, an estimated $844K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Westover Capital Advisors opened a new position in Janus Henderson AAA CLO ETF worth $1.79M.

  • Westover Capital Advisors's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 35,269 shares worth $1.79M.
  • Westover Capital Advisors added most to US Foods in Q4 2024, an estimated $1.12M increase.
  • Westover Capital Advisors's biggest Q4 2024 reduction was State Street SPDR Portfolio Long Term Treasury ETF, cutting an estimated $11M.
  • Westover Capital Advisors fully exited AstraZeneca in Q4 2024, selling an estimated $844K.
  • Westover Capital Advisors's ten largest holdings make up 35% of its $454M portfolio in Q4 2024.
  • Westover Capital Advisors opened 12 new positions and closed 18 in Q4 2024.
  • Westover Capital Advisors's portfolio value fell 13% quarter-over-quarter to $454M.

Based on Westover Capital Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.